HAMPTON, Va., April 27, 2016 -- Patient Advocate Foundation (PAF), a national nonprofit dedicated to helping those living with serious illness overcome access-to-care issues, is pleased to announce the one-year anniversary of its Metastatic Melanoma and Metastatic Lung Cancer Transportation Financial Aid Fund: a national transportation relief program for qualified patients undergoing recurring IV-infused treatment.
"Transportation continues to be a burden for those requiring frequent access to care across the U.S.," Alan Balch, PhD, CEO of Patient Advocate Foundation says. "We are pleased to continue to offer this resource for patients."
Approved patients receive a one-time grant of $300 to be used specifically for transportation purposes as it applies to the patient's current treatment plan, including but not limited to: ambulance rides, airfare, train, public transportation, taxi or similar service, as well as necessary gas or oil for a vehicle. Patients may also use the funds for car insurance, vehicle repair, auto loans, and vehicle adaptations or modifications such as wheelchair accessibility.
"Our data reveals that when patients do not have access to reliable transportation they are more likely to experience missed or delayed treatment, as well as issues accessing their prescribed medication", Balch adds (1). "By working to eliminate that barrier, we can help patients get and stay on their prescribing physicians' treatment regimen, leading to better health outcomes nationwide."
This program is a part of PAF's Financial Aid Fund division offering targeted relief to specific designated patient populations. Patients interested in applying for the Transportation Financial Aid Fund may call (855) 824-7941 for more information or visit www.patientadvocate.org/programs.
(1) Patient Advocate Foundation, Patient Data Analysis Report, 2015 Edition.
About the Patient Advocate Foundation (PAF) Financial Aid Fund-Patient Advocate Foundation's Financial Aid Fund serves as an independent division of Patient Advocate Foundation, providing small grants to patients who meet the financial and medical criteria. Grants are provided on first-come first served basis and are distributed until funds are depleted. Qualifications and processes for each fund may differ based on fund requirements. Patients who are interested in applying for financial assistance should start by calling this division toll free at (855) 824-7941 or visiting www.patientadvocate.org/programs.
CONTACT: Erin Singleton, Chief of Mission Delivery, Patient Advocate Foundation, 757-952-0561


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



